Furazolidone in the treatment of institutional shigellosis.
D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D005664:Furazolidone / Q000008:administration & dosage / Q000627:therapeutic use*; D006778:Hospitals, Psychiatric; D006801:Humans; D009355:Neomycin / Q000627:therapeutic use; D012760:Shigella / Q000187:drug effects; D013307:Streptomycin / Q000627:therapeutic use; D013414:Sulfaguanidine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D013449:Sulfonamides; D013414:Sulfaguanidine; D005664:Furazolidone; D002701:Chloramphenicol; D013752:Tetracycline; D009355:Neomycin; D013307:Streptomycin